These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12642727)

  • 1. Hiatal hernia mimics centrally necrotic cancer in the lung on FDG positron emission tomographic imaging.
    Bhargava P; Zhuang H; Alavi A
    Clin Nucl Med; 2003 Apr; 28(4):347-9. PubMed ID: 12642727
    [No Abstract]   [Full Text] [Related]  

  • 2. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of F-18 FDG by a hiatal hernia.
    Ahn SH; Scheiner JD; Noto RB
    Clin Nucl Med; 2002 Oct; 27(10):733-4. PubMed ID: 12352120
    [No Abstract]   [Full Text] [Related]  

  • 4. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker.
    Tanaka R; Emerson LL; Karwande SV; Schreiber G
    Chest; 2005 May; 127(5):1848-51. PubMed ID: 15888868
    [No Abstract]   [Full Text] [Related]  

  • 5. The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging.
    Ponzo F; Zhuang H; Woodfield C; Alavi A
    Clin Nucl Med; 2003 Feb; 28(2):146-9. PubMed ID: 12544141
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual-phase F-18 FDG PET cannot increase the diagnostic accuracy to differentiate solitary pulmonary nodules.
    Chen YK; Shen YY; Kao CH
    Clin Nucl Med; 2004 Apr; 29(4):281-3. PubMed ID: 15096984
    [No Abstract]   [Full Text] [Related]  

  • 7. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G
    J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract]   [Full Text] [Related]  

  • 8. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
    Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
    Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
    Kapucu LO; Meltzer CC; Townsend DW; Keenan RJ; Luketich JD
    J Nucl Med; 1998 Jul; 39(7):1267-9. PubMed ID: 9669408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography.
    Wilkinson MD; Fulham MJ; McCaughan BC; Constable CJ
    Clin Nucl Med; 2003 Mar; 28(3):234-5. PubMed ID: 12592137
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
    Hsu WH; Hsu NY; Shen YY; Yen RF; Kao CH
    Cancer Invest; 2003; 21(1):47-52. PubMed ID: 12643009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
    Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
    AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive FDG positron emission tomography in pulmonary amyloidosis.
    Ollenberger GP; Knight S; Tauro AJ
    Clin Nucl Med; 2004 Oct; 29(10):657-8. PubMed ID: 15365447
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positron-emission tomography in the evaluation of lung cancer].
    Torres García AJ; Carreras Delgado JL
    Arch Bronconeumol; 1997 Dec; 33(11):553-5. PubMed ID: 9508470
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dietary intake before F-18 FDG positron emission tomographic scanning on the evaluation of a solitary pulmonary nodule.
    Ojha B; Bartley SC; Gundlapalli S; Mountz JM
    Clin Nucl Med; 2001 Nov; 26(11):908-9. PubMed ID: 11595840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
    Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
    AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a review.
    Divisi D; Barone M; Zaccagna G; Crisci R
    Ann Med; 2017 Nov; 49(7):626-635. PubMed ID: 28590774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL; Fischman AJ
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.